Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 9/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 6/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31587115 | 0.92 | CACNA1H (0.43) | CACNA1HDRD2HCRTR2PKMSIGMAR1 | |
| SCHEMBL8807716 | 0.81 | LMNA (0.49) | CACNA1HDRD2SIGMAR1 | |
| SCHEMBL12021262 | 0.80 | ACKR3 (0.44) | CACNA1HDRD2HCRTR2 | |
| SCHEMBL16020333 | 0.80 | ACKR3 (0.44) | CACNA1HDRD2HCRTR2 | |
| SCHEMBL13492044 | 0.80 | ACKR3 (0.44) | CACNA1HDRD2HCRTR2 | |
| SCHEMBL7385015 | 0.80 | DRD2 (0.43) | CACNA1HDRD2ITGB3ITGA2B | |
| SCHEMBL7387215 | 0.80 | DRD2 (0.43) | CACNA1HDRD2ITGB3ITGA2B | |
| SCHEMBL7385013 | 0.80 | DRD2 (0.43) | CACNA1HDRD2ITGB3ITGA2B | |
| SCHEMBL21071400 | 0.79 | CACNA1H (0.38) | CACNA1HDRD2HCRTR2 | |
| SCHEMBL21069493 | 0.79 | CACNA1H (0.38) | CACNA1HDRD2HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0774460-A1 | BENZOIC ACID COMPOUND AND USE THEREOF AS MEDICINE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |